These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14454390)

  • 1. The present status of the management of atherosclerosis.
    KATZ LN; PICK R
    Cardiol Prat; 1962 Feb; 13():54-71. PubMed ID: 14454390
    [No Abstract]   [Full Text] [Related]  

  • 2. The prophylactic management of coronary atherosclerosis.
    ENGELBERG H
    Geriatrics; 1956 Jun; 11(6):243-8. PubMed ID: 13318371
    [No Abstract]   [Full Text] [Related]  

  • 3. Manager's disease; prevention of coronary sclerosis.
    ATTINGER E
    Schweiz Med Wochenschr; 1956 Jul; 86(28):806-8. PubMed ID: 13351592
    [No Abstract]   [Full Text] [Related]  

  • 4. [Certain problems of hypertension, atherosclerosis and coronary insufficiency. Perspectives for further studies].
    MJASNIKOV AL
    Cesk Zdrav; 1961 Feb; 9():82-92. PubMed ID: 13771553
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nation-wide program for the prevention of atherosclerosis. Physicians, patients and health insurance carriers must all pull together].
    Platzer H
    MMW Fortschr Med; 2003 Mar; 145(13):37-8. PubMed ID: 15101531
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention and control of chronic disease. I. Cardiovascular disease--with particular attention to atherosclerosis.
    OLSON RE
    Am J Public Health Nations Health; 1959 Sep; 49(9):1120-8. PubMed ID: 14428824
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physical exercise in the prevention of coronary atherosclerosis in the evaluation of the tolerance of the heart to exercise].
    Bisteni A
    Arch Inst Cardiol Mex; 1985; 55(5):377-9. PubMed ID: 2935092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Strategies for the prevention of coronary heart disease: a policy statement of the Israel Atherosclerosis Society].
    Eisenberg S; Beigel I; Yeshuron D; Modan M; Kaufman N; Kark J; Rubinstein A; Stein Y
    Harefuah; 1988 Mar; 114(6):295-303. PubMed ID: 3371780
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the mural coronary artery in prevention of coronary atherosclerosis.
    Lee SS; Wu TL
    Arch Pathol; 1972 Jan; 93(1):32-5. PubMed ID: 5006997
    [No Abstract]   [Full Text] [Related]  

  • 10. Lipoproteins and atherosclerosis in children: an early marriage?
    Strong JP; Zieske AW; Malcom GT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11 Suppl 5():16-22. PubMed ID: 12063771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of coronary heart disease: the recommendations of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.
    Hansson L; Mancia G; Zanchetti A
    J Hypertens; 1995 Feb; 13(2):161-2. PubMed ID: 7615945
    [No Abstract]   [Full Text] [Related]  

  • 12. Premature coronary heart disease in systemic lupus erythematosus: what risk factors do we understand?
    Nikpour M; Gladman DD; Urowitz MB
    Lupus; 2013 Oct; 22(12):1243-50. PubMed ID: 24097996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Joint recommendations of Israel medical societies for prevention of coronary heart disease and atherosclerosis].
    Harats D; Rubinstein A
    Harefuah; 2000 Jan; 138(1):66-74. PubMed ID: 10868184
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care.
    Turner DA; Paul S; Stone MA; Juarez-Garcia A; Squire I; Khunti K
    Heart; 2008 Dec; 94(12):1601-6. PubMed ID: 18450843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection and treatment of high blood cholesterol for prevention of coronary heart disease--attitude of the Israel Society of Atherosclerosis].
    Rubinstein A
    Harefuah; 1995 May; 128(9):551-6. PubMed ID: 7797157
    [No Abstract]   [Full Text] [Related]  

  • 16. The epidemic of the 20(th) century: coronary heart disease.
    Dalen JE; Alpert JS; Goldberg RJ; Weinstein RS
    Am J Med; 2014 Sep; 127(9):807-12. PubMed ID: 24811552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of lipid disorders for coronary heart disease prevention according to International Atherosclerosis Society recommendations].
    Idzior-WaluĊ› B
    Przegl Lek; 1999; 56(5):372-6. PubMed ID: 10554575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.
    Frisinghelli A; Mafrici A
    Clin Drug Investig; 2007; 27(9):591-604. PubMed ID: 17705568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature coronary heart disease in SLE: can we prevent progression?
    Iaccarino L; Bettio S; Zen M; Nalotto L; Gatto M; Ramonda R; Punzi L; Doria A
    Lupus; 2013 Oct; 22(12):1232-42. PubMed ID: 24097995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Strategy for the prevention of ischemic heart disease. Directives from the European Society of Atherosclerosis].
    Assmann G; Lewis B; Mancini M; Paoletti R; Schettler G
    Rev Esp Cardiol; 1987; 40(1):8-9. PubMed ID: 3823588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.